It is estimated that one-third of the world's population is infected with M
ycobacterium tuberculosis, but that only 10% of infected people break down
with the disease. In the remaining 90% the infection remains clinically lat
ent. In the present study, the immune mechanisms controlling the latent pha
se of tuberculosis infection were evaluated in a mouse model of latency and
reactivation. Mice aerosol-infected with M. tuberculosis were treated with
anti mycobacterial drugs resulting in very low, stable bacterial numbers (
<500 CFU in the spleen and lung) for 10-12 weeks followed by reactivation o
f the disease with increasing bacterial numbers. During latency, pathologic
al changes in the lung had almost completely resolved and lymphocyte number
and turnover were at the pre-infection level. The CD4 subset was highly ac
tive during the acute phase of infection and could be detected by intracell
ular staining for IFN-<gamma> as well as after antigen-specific stimulation
with mycobacterial antigens. The CD8 subset was not involved in the acute
stage of infection, but this subset was active and produced IFN-gamma durin
g the latent phase of infection. In vivo depletion of T cell subsets suppor
ted these findings with a 6-7-fold increase in bacterial numbers in the lun
g following anti-CD4 treatment during the acute phase, while anti-CD8 treat
ment did not have an effect. The opposite was found during the latent phase
where anti-CD8 treatment as well as anti-IFN-gamma treatment both resulted
in a 10-fold increase in bacterial numbers in the lung, while anti-CD4 tre
atment induced only a modest change.